Documente Academic
Documente Profesional
Documente Cultură
ISO 13485:2016
Section by section details of changes
About the Presenter
Mark Swanson (CMQ/OE, CQE, CBA) In addition to this, Mark is currently the Director of the Medical
Technology Quality Graduate program at St. Cloud State Universitys
is the President and lead consultant of Twin Cities Graduate Center in Maple Grove, Minnesota. This
H&M Consulting Group; a group innovative program was started in 2012 to provide quality
professionals with graduate level learning in the application of quality
focused on helping small to mid-sized management principles, particularly for those in the key Minnesota
and quality systems knowledge as the Mark has spent close to 4 years being an active member of ISO
large medical device companies. Technical Committee 210 (TC210), Working Group 1 (WG1) working
on the revision of ISO 13485:2003 that is on track to be released in
February 2016 and has also participated with ISO TC176, WG24 on
ISO 9001:2015. This work includes discussions regarding the impact
of changes on the ISO quality management system standards, the
integration of different management standards and how to
effectively integrate the different ISO standards and other
regulations into a single quality management system.
Changes to Introduction
Clarification of concepts
Clarification that it does not include environmental, occupational, health & safety,
or financial management
Changes to Scope
Scope includes organizations that have a role in one or more stages of the life-
cycle
Reorganized paragraphs
Output: Documentation of review must include the input reviewed and changes
needed to respond to new/revised regulatory requirements in addition to any
other action
Changes to Resource Management
Infrastructure
Planning
Maintain (update) planning documents
Inputs
Outputs
In a form suitable for verification against design & development input
Approved prior to product release
Verification
Planned & documented arrangements
Plan includes: Method, acceptance criteria and statistical technique with rationale for
sample size
Connection to other devices
Report includes: Results (same) and conclusions (new)
Validation
See above
Clinical/performance evaluation not released for use (from notes in the 2003 version).
Use of production units (representative product)/document equivalency (rationale for
choice of product)
Clinical evaluation or performance evaluation in accordance with regulatory
requirements.
Changes to Product Realization - Design & Development (cont.)
Change Control
Document procedures
Determine significance of change to function, performance, usability, safety &
regulatory requirements
Purchasing (expanded)
Purchasing information
Addition of requirements for qualification of supplier personnel
Notification of changes (written agreement)
Installation
Documented requirements for installation and verification of installation
Servicing activities
Providing documented procedures, materials and required measurement/
equipment for servicing
Analysis of recordscomplaint determination and source for improvement
Changes to Product Realization - Design & Development (cont.)
Sterilizationbatch records
Validation
Both production and service
Proportionate to risk
Identification
Status throughout product realization
If regulatory requirements require unique device ID
Reference to 10012
Record adjustments
Feedback
Rework
Separate section
Procedure required
Changes to Measurement, Analysis & Improvement (cont.)
Analysis of Data
Added audits and service reports as input
Statistical techniquesapplicable methods
Improvement
GeneralEvaluate product safety and effectiveness and use of post market
surveillance added
Corrective Action
without undue delay
Update of documentation
Verify ability to meet requirements is not adversely affected
Preventive Actionmatch with corrective action with add of potential (except
no review of nonconformity or undue delay)